TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody.

Ben Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.